|
Apr 24
|
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
|
|
Apr 23
|
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
|
|
Apr 22
|
Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?
|
|
Apr 12
|
Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
|
|
Apr 8
|
Down 75%. Is Agenus Stock a Buy on the Dip?
|
|
Apr 5
|
Agenus Announces Reverse Stock Split of Common Stock
|
|
Apr 3
|
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
|
|
Mar 24
|
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
|
|
Mar 17
|
US$5.50: That's What Analysts Think Agenus Inc. (NASDAQ:AGEN) Is Worth After Its Latest Results
|
|
Mar 15
|
Agenus Inc. (NASDAQ:AGEN) Q4 2023 Earnings Call Transcript
|
|
Mar 15
|
Analysts Just Shaved Their Agenus Inc. (NASDAQ:AGEN) Forecasts Dramatically
|
|
Mar 14
|
Agenus (AGEN) Q4 2023 Earnings Call Transcript
|
|
Mar 14
|
Agenus Inc (AGEN) Reports Full Year and Q4 2023 Financial Results, Advances in Oncology Pipeline
|
|
Mar 14
|
Agenus Reports Fourth Quarter and Full Year 2023 Results
|
|
Mar 6
|
Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
|
|
Mar 5
|
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Feb 29
|
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
|
|
Feb 26
|
Agenus to Participate in Leerink Partners Global Biopharma Conference
|
|
Jan 22
|
Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
|
|
Jan 16
|
Institutional investors may adopt severe steps after Agenus Inc.'s (NASDAQ:AGEN) latest 16% drop adds to a year losses
|